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Pulmonary tuberculosis (TB) is the most common form of TB. Primary infection can also
affect the pharynx, cervical lymph node, intestine, or oral mucosa. Historically, the
observed incidence of concomitant infection with leprosy and TB is high. However, reports
of concomitant infection in modern literature remain scarce. Most cases reported in the lit-
erature had borderline/lepromatous leprosy and pulmonary tuberculosis. Extrapulmonary
tuberculosis is reported in only 3.2% of leprosy cases. To the best of our knowledge, this is
the first case report of primary oral tuberculosis of the tongue in a patient with
lepromatous leprosy with Type 2 lepra reaction. The patient was referred to Directly
Observed Treatment, Short-Course clinic and started on Category I treatment. She received
oral prednisolone for lepra reaction, which was subsequently tapered and stopped, how-
ever, she continued to receive other antileprotic drugs (thalidomide and clofazimine).
The patient’s general condition improved and she is on regular follow up.
 2015 Asian African Society for Mycobacteriology. Production and hosting by Elsevier Ltd.
All rights reserved.ple tissue from the tip of the tongue was collected and sent
Case report
A 45-year-old female came to the outpatient department with
complaints of low-grade fever for 2 weeks, erythema and
edema of the whole body, and painless ulcers in the tip of
the tongue. She had a history of leprosy, which was treated
and cured 15 years ago. In the dermatology outpatient depart-
ment, she was evaluated for leprosy. Slit-skin smear was
taken from different sites such as the nose, eyebrows,
earlobes, and the results indicated 4+ grading for all the
aforementioned samples. Based on this result, the patient
was diagnosed as a case of lepromatous leprosy with Type 2
reaction and we decided to treat her with multidrug therapy.To examine the pathology of the ulcer of the tongue, sam-
for various examinations such as KOH mount and fungal
culture, Giemsa stain for histoplasmosis, bacterial culture
and acid-fast staining, and histopathological examination.
Surprisingly, Ziehl–Neelsen staining showed acid-fast bacilli,
which were beaded and not uniformly stained, a finding char-
acteristic of tubercle bacilli. Histopathological examination of
the sample showed a granulomatous reaction with central
caseous necrosis and epithelioid and giant cells suggestive
of tuberculosis (Fig. 1).
Nested polymerase chain reaction was performed after
extracting the DNA from the sample tissue. The extractedmil Nadu,
Fig. 1 – Histopathological examination showing central caseous necrosis and epithelioid and giant cells suggestive of
tuberculosis.
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IS6110 (insertion sequence), which is specific for
Mycobacterium tuberculosis. After amplification, gel elec-
trophoresis was carried out, which showed a band corre-
sponding to IS6110 (219 bp; Fig. 2). Based on this result, oral
tuberculosis of the tongue was diagnosed. To identify the pri-
mary focus of infection, we carried out further examinations.
Chest X-ray showed clear lung fields without features of
tuberculosis. Computed tomography of the thorax and abdo-
men did not reveal any primary focus. Venereal Disease
Research Laboratory and human immunodeficiency virus
(HIV) tests were not reactive. A provisional diagnosis of pri-
mary oral tuberculosis of the tongue in lepromatous leprosy
was made and we initiated treatment for both leprosy and
tuberculosis. The patient was advised to stop taking dapsone
and instead received oral prednisolone, thalidomide, and clo-
fazimine. The patient was referred to the Directly Observed
Treatment, Short-Course clinic and started on Category I
treatment. The oral prednisolone dose was subsequently
tapered and stopped, however, she continued to receive the
other antileprotic drugs. The patient’s general condition
improved and she was on regular follow up. We obtained
Institutional Ethical Committee approval and informed con-
sent from the patient for reporting this case.Discussion
Historically, the observed incidence of concomitant infection
with leprosy and tuberculosis (TB) is high. However, reports
of concomitant infection in modern literature remain scarce.Estimation of the annual new case detection rate (ANCDR) in
India, where both TB (ANCDR 181/100,000 in 2011) [1] and
leprosy (ANCDR 10–35/100,000 in 2011) [2] remain endemic,
suggests that only 0.019 cases of concomitant infec-
tion/100,000 population would be detected.
It is hypothesized that reduced cell-mediated immunity
plays a role in reactivation of latent TB or superinfection with
TB inmultibacillary patients. Trindade et al. [3] recently inves-
tigated the cell-mediated responses of two patients who were
diagnosed with borderline leprosy and TB [3]. However, they
were unable to find any aberrant response of the interferon-
gamma/interleukin-12/23 axis on immunological evaluation.
Therefore, further studies are needed to support this
hypothesis.
Although there are many well-known risk factors for TB,
including HIV infection, diabetes mellitus, transplant patients
on immunosuppression, and birth and travel in the develop-
ing world, the use of steroids and development of TB are con-
troversial. One weakness in the argument for steroids
increasing the risk of developing TB is that a large number
of leprosy patients, especially those with multibacillary
leprosy, go on to develop lepra reactions, which require ster-
oid treatment. This means that there is a high rate of steroid
prescriptions in leprosy cases. With an estimated ANCDR for
co-infection of 0.019/100,000 patients (in India), the incidence
of patients started on steroids is approximately 66 times
greater than the estimated incidence of co-infection with
both diseases [4]. Therefore, longitudinal work with active
screening of patients before commencing treatment is neces-
sary to identify any temporal relationship between steroids
and TB development.
Fig. 2 – Gel electrophoresis of nested PCR amplicons showing bands corresponding to IS6110 (219 bp). Note: IS = insertion
sequence; M =molecular ladder; PC = positive control; PCR = polymerase chain reaction; T = test.
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tous leprosy and pulmonary tuberculosis. Extrapulmonary
tuberculosis was reported in only 3.2% of leprosy cases. This
includes cutaneous, lymph node, and central nervous system
tuberculosis [4]. To date, only one case of co-infection of
leprosy and oral tuberculosis (larynx) [5] was reported in the
literature.
Oral manifestation of tuberculosis is a rare occurrence,
observedonly in 0.05–5%of theTBpopulation [6]. Saliva, sapro-
phytes, and the very high integrity of oral epitheliumwith stri-
ated muscles resist the bacterial invasion. Usually, oral
tuberculosis is secondary to pulmonary involvement and pre-
sents as a single indurated painful ulcer especially in middle
aged and elderly individuals. Primary oral tuberculosis pre-
senting as a single painless ulcer in younger individuals is
uncommon. The most common site is the lateral margins of
the tongue, which rest against rough, sharp, and broken teeth.
Any area of chronic irritation or inflammationmay favor local-
ization ofMycobacterium associated with the disease [7].
Infectious etiologies to be evaluated include primary syphi-
lis and deep fungal diseases such as histoplasmosis. Noninfec-
tious etiology includes traumatic ulcer and squamous cell
carcinoma.Whenoral lesions of tuberculosis are the soleman-
ifestations of the disease, the clinician may face a diagnostic
challenge. Another concern is whether there is an increased
risk of rifampicin resistance in undiagnosed tuberculosis
co-infection due to multidrug therapy. Although this may be
an unlikely consequence of monthly rifampicin treatment in
India, it may be a greater concern in regions where leprosy
patients take daily rifampicin, such as in the United States.Conclusion
The relationship between the two mycobacterial diseases
continues to be enigmatic despite decades of research.
Nowadays, oral manifestations of TB are reappearing along-
side many forgotten extrapulmonary infections. Recognition
of oral tuberculosis is important to prevent emergence of
rifampicin-resistant tuberculosis during treatment of leprosy.
These patients require interdisciplinary management and
social support.Conflicts of interest
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